Interim 2019/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020
Angela Rose, Hanne‐Dorthe Emborg(Statens Serum Institut), Jim McMenamin(Public Health Scotland), Marta Valenciano(World Health Organization), Ramona Trebbien(Ministry of External Affairs), Esther Kissling, Francisco Pozo(Instituto de Salud Carlos III), Amparo Larrauri(Instituto de Salud Carlos III), Heather Whitaker(Public Health Agency of Canada), Clara Mazagatos(Instituto de Salud Carlos III)
Cited by 66
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
|Antimicrobial Agents and Chemotherapy|2001|653